Successful desensitization protocol for pyridostigmine in a 12 year old patient with myasthenia gravis
Background. Myasthenia gravis is a chronic, autoimmune disease with muscle weakness. Acetylcholinesterase inhibitors are used in the symptomatic treatment of the disease. Allergic reaction to pyridostigmine bromide is rare. In the literature, no allergic reaction to pyridostigmine bromide has...
Saved in:
| Main Authors: | Fatih Kaplan, Erdem Topal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hacettepe University Institute of Child Health
2023-04-01
|
| Series: | The Turkish Journal of Pediatrics |
| Subjects: | |
| Online Access: | https://turkjpediatr.org/article/view/38 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Celebrating the 70 years of pyridostigmine on therapy of Myasthenia Gravis: historical aspects of the preliminary trials
by: Paulo José LORENZONI, et al.
Published: (2020-03-01) -
Neonatal Myasthenia Gravis
by: J Gordon Millichap
Published: (1988-09-01) -
IMMUNOPATHOGENESIS OF MYASTHENIA GRAVIS (REVIEW)
by: E. D. Gasymly
Published: (2018-06-01) -
Treatment Approaches for Bronchopulmonary Infection in Myasthenia Gravis Patients
by: V. I. Sokolova, et al.
Published: (2020-05-01) -
Myasthenia gravis in children: analysis of 18 patients
by: Morita Maria da Penha A., et al.
Published: (2001-01-01)